z-logo
Premium
Letter: questions regarding the diagnostic performance of serum assays for atrophic gastritis—Authors' reply
Author(s) -
Zagari R. M.,
Greenwood D. C.
Publication year - 2017
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.14369
Subject(s) - medicine , atrophic gastritis , gastritis , gastroenterology , dermatology , stomach
diagnosis and prevention in subjects with Helicobacter pylori-related chronic gastritis. In: Tonino P, ed. Gastritis and Gastric Cancer – New Insights in Gastroprotection, Diagnosis and Treatments. Rijeka: InTech; 2011:179-196. 4. Kawai T, Miki K, Ichinose M, et al. Changes in evaluation of the pepsinogen test result following Helicobacter pylori eradication therapy in Japan. Inflammopharmacology. 2007;15:31-35. 5. Urita Y, Hike K, Torii N, et al. Serum pepsinogens as a predicator of the topography of intestinal metaplasia in patients with atrophic gastritis. Dig Dis Sci. 2004;49:795-801. 6. Leja M, Camargo MC, Polaka I, et al. Detection of gastric atrophy by circulating pepsinogens: a comparison of three assays. Helicobacter. 2017;22:e016999.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom